Decreased exposure to sunitinib due to concomitant administration of ifosfamide: results of a phase I and pharmacokinetic study on the combination of sunitinib and ifosfamide in patients with advanced solid malignancies

被引：0
|
作者：
P Hamberg
N Steeghs
W J Loos
D van de Biessen
M den Hollander
M Tascilar
J Verweij
H Gelderblom
S Sleijfer
机构：
[1] Erasmus University Medical Center Daniel Den Hoed Cancer Center,Department of Medical Oncology
[2] Leiden University Medical Center,Department of Medical Oncology
来源：
British Journal of Cancer | 2010年 / 102卷
关键词：
sunitinib; ifosfamide; pharmacokinetic; VEGF; drug-interaction; phase I;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1699 / 1706
页数：7
相关论文
共 50 条
  • [41] Phase I-II study of docetaxel and ifosfamide combination in patients with anthracycline pretreated advanced breast cancer
    Kosmas, C
    Tsavaris, N
    Malamos, N
    Stavroyianni, N
    Gregoriou, A
    Rokana, S
    Polyzos, A
    BRITISH JOURNAL OF CANCER, 2003, 88 (08) : 1168 - 1174
  • [42] Feasibility study of two schedules of sunitinib in combination with pemetrexed in patients with advanced solid tumors
    Okamoto, Isamu
    Shimizu, Toshio
    Miyazaki, Masaki
    Tsurutani, Junji
    Ichikawa, Yasuko
    Terashima, Masaki
    Takeda, Masayuki
    Fumita, Soichi
    Ohki, Emiko
    Kimura, Nobuyuki
    Hashimoto, Junichi
    Nakagawa, Kazuhiko
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (02) : 639 - 646
  • [43] Feasibility study of two schedules of sunitinib in combination with pemetrexed in patients with advanced solid tumors
    Isamu Okamoto
    Toshio Shimizu
    Masaki Miyazaki
    Junji Tsurutani
    Yasuko Ichikawa
    Masaki Terashima
    Masayuki Takeda
    Soichi Fumita
    Emiko Ohki
    Nobuyuki Kimura
    Junichi Hashimoto
    Kazuhiko Nakagawa
    Investigational New Drugs, 2012, 30 : 639 - 646
  • [44] Phase I Study of Dalteparin in Combination With Sunitinib in Patients With Metastatic Clear Cell Renal Carcinoma
    Wentink, Madelon Q.
    Verheul, Henk M. W.
    Pal, Sumanta K.
    George, Saby
    Voortman, Johannes
    Danchaivijitr, Pongwut
    Adelaiye, Remi
    Poslinski, Diane
    Groman, Adrienne
    Hutson, Alan
    Pili, Roberto
    CLINICAL GENITOURINARY CANCER, 2018, 16 (01) : E1 - E9
  • [45] Cabazitaxel in patients with advanced solid tumours: Results of a Phase I and pharmacokinetic study
    Dieras, V.
    Lortholary, A.
    Laurence, V.
    Delva, R.
    Girre, V.
    Livartowski, A.
    Assadourian, S.
    Semiond, D.
    Pierga, J. Y.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (01) : 25 - 34
  • [46] Pharmacokinetic results of a phase I trial of sorafenib in combination with dacarbazine in patients with advanced solid tumors
    Erich Brendel
    Matthias Ludwig
    Chetan Lathia
    Caroline Robert
    Stanislas Ropert
    Jean-Charles Soria
    Jean-Pierre Armand
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 53 - 61
  • [47] Pharmacokinetic results of a phase I trial of sorafenib in combination with dacarbazine in patients with advanced solid tumors
    Brendel, Erich
    Ludwig, Matthias
    Lathia, Chetan
    Robert, Caroline
    Ropert, Stanislas
    Soria, Jean-Charles
    Armand, Jean-Pierre
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (01) : 53 - 61
  • [48] A phase I study of sunitinib in combination with FOLFIRI in patients with untreated metastatic colorectal cancer
    Starling, N.
    Vazquez-Mazon, F.
    Cunningham, D.
    Chau, I.
    Tabernero, J.
    Ramos, F. J.
    Iveson, T. J.
    Saunders, M. P.
    Aranda, E.
    Countouriotis, A. M.
    Ruiz-Garcia, A.
    Wei, G.
    Tursi, J. M.
    Guillen-Ponce, C.
    Carrato, A.
    ANNALS OF ONCOLOGY, 2012, 23 (01) : 119 - U110
  • [49] Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies
    Sayar, H.
    Shen, Z.
    Lee, S. J.
    Royce, M.
    Rabinowitz, I.
    Lee, F.
    Smith, H.
    Eberhardt, S.
    Maestas, A.
    Lu, H.
    Verschraegen, C.
    INVESTIGATIONAL NEW DRUGS, 2009, 27 (02) : 153 - 158
  • [50] Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies
    H. Sayar
    Z. Shen
    S. J. Lee
    M. Royce
    I. Rabinowitz
    F. Lee
    H. Smith
    S. Eberhardt
    A. Maestas
    H. Lu
    C. Verschraegen
    Investigational New Drugs, 2009, 27 : 153 - 158
12345